Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated with Ustekinumab

Next Previous
X
Search
Trial Profile

Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated with Ustekinumab

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 19 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
  • Indications Crohn's disease
  • Focus Registrational; Therapeutic Use
  • Acronyms STARDUST; STARDUST LTE
  • Sponsors Janssen-Cilag

    • Most Recent Events

    • 30 Nov 2023 Results (n=323) from long-term extension period assessing clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease through week 104 published in the Alimentary Pharmacology and Therapeutics
    • 11 Oct 2022 Results (n=323) assessing the long-term extension period for health-related quality of life measures and the effect of ustekinumab on work productivity and activity impairment at week 104, comparing treat-to-target and standard of care, presented at the 30th United European Gastroenterology Week.
    • 11 Oct 2022 Results of incorporated-intestinal ultrasound sub-study (n=77) assessing incorporated-intestinal ultrasound endpoints and their relation-ship with ustekinumab exposure presented at the 30th United European Gastroenterology Week.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top